Title:
PLASMA KALLIKREIN BINDING PROTEIN
Document Type and Number:
Japanese Patent JP2022188112
Kind Code:
A
Abstract:
To provide a plasma kallikrein binding protein and use method thereof.SOLUTION: A plasma kallikrein binding protein binds to or competes for binding with a protein (for example, epi-Kal2) and/or a same epitope as a low molecule (AEBSF, for example), and does not bind to a pre-plasma kallikrein. The plasma kallikrein binding protein may have a full length (for example, IgG, IgM, IgA, IgD and IgE) or may include only an antigen binding fragment (for example, Fab, F(ab')2 or scFv fragment). The binding protein may include two heavy chain immunoglobulins and two light chain immunoglobulins or may have a single chain antibody.SELECTED DRAWING: None
Inventors:
DANIEL J SEXTON
MALINI VISWANATHAN
MALINI VISWANATHAN
Application Number:
JP2022150541A
Publication Date:
December 20, 2022
Filing Date:
September 21, 2022
Export Citation:
Assignee:
TAKEDA PHARMACEUTICAL
International Classes:
C12N15/13; A61K38/02; A61K38/16; A61K39/395; A61P9/00; A61P29/00; A61P31/04; A61P35/00; C07K16/40; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63
Attorney, Agent or Firm:
Ryoichi Takaoka
Nao Oda
Akiyo Iwahori
Rena Miyoshi
Kamoto Takahashi
Nao Oda
Akiyo Iwahori
Rena Miyoshi
Kamoto Takahashi